Pharmaceutical News

Articles tagged with “Pharmaceutical News”

1 article

BXCL501 Phase 2a Trial Targets Acute Stress & PTSD Prevention

A new DoD-backed Phase 2a trial tests BXCL501 for acute stress reactions and PTSD prevention. Here's what this means for patients exploring trauma treatment.

Mar 22, 2026

Read

Back to all articles

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.

Contact the site